PLA2R1 and membranous glomerulonephritis: The introduction of non-invasive diagnostic markers, such as anti-PLA2R antibodies for membranous nephropathy, undoubtedly altered biopsy referral patterns over the study period, acting as a significant unmeasured confounder in the temporal analysis of primary glomerulonephritis.